Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

ValiRx (VAL) Regulatory News

Date Source Headline
28th May 2024 7:00 am RNS Investor Webinar
20th May 2024 12:00 pm RNS Business Update
16th May 2024 7:00 am RNS Further re Final Results
15th May 2024 7:00 am RNS Final Results and Notice of AGM
22nd Apr 2024 7:00 am RNS Directorate Changes
21st Mar 2024 7:00 am RNS Evaluation Agreement with Imperial College London
19th Mar 2024 7:00 am RNS Board Re-structuring and update on requisition
4th Mar 2024 5:47 pm RNS Shareholder Requisition Notice
4th Mar 2024 7:00 am RNS Proposed Appointment of Non-Executive Director
29th Feb 2024 2:00 pm RNS Proposed Appointment of Non-Executive Director
13th Feb 2024 2:20 pm RNS Further re Shareholder Requisition Notice
9th Feb 2024 5:06 pm RNS Shareholder Requisition Notice
19th Jan 2024 7:00 am RNS Change of Broker
18th Jan 2024 7:00 am RNS Directorate Change
4th Jan 2024 1:48 pm RNS Result of GM, Issue of Equity
19th Dec 2023 6:11 pm RNS Result of Retail Offer, Subscription
15th Dec 2023 7:00 am RNS Posting of Circular, Notice of GM and Ops Review
13th Dec 2023 4:56 pm RNS Retail Offer
13th Dec 2023 4:49 pm RNS Conditional Fundraise, Notice of General Meeting
5th Dec 2023 7:00 am RNS Agreement to License VAL401 to Ambrose Healthcare
10th Nov 2023 7:00 am RNS Evaluation Agreement with StingRay Bio
6th Oct 2023 10:45 am RNS Statement re Share Price Movement
28th Sep 2023 7:00 am RNS Operational Review
24th Aug 2023 7:00 am RNS Half-year Report
14th Aug 2023 7:00 am RNS Collaborative Services Agreement
19th Jul 2023 7:00 am RNS Inaphaea BioLabs secures first external contract
28th Jun 2023 2:15 pm RNS Result of AGM
20th Jun 2023 7:00 am RNS Virtual AGM Access
19th Jun 2023 7:00 am RNS Inaphaea BioLabs Operational Update
16th Jun 2023 7:00 am RNS Conclusion of Hokkaido Evaluation Agreement
14th Jun 2023 7:00 am RNS Asset Purchase – Imagen Therapeutics
8th Jun 2023 7:00 am RNS Update on proposed sub-license of VAL201
7th Jun 2023 7:00 am RNS Expanded agreement with University of Barcelona
5th Jun 2023 7:00 am RNS Final Results and Notice of AGM
26th May 2023 7:00 am RNS Notice of Results and Investor Webinar
26th Apr 2023 7:00 am RNS Collaborative Services Agreement
31st Mar 2023 7:00 am RNS Quarterly Operational Update
1st Mar 2023 7:02 am RNS Investor Webinar
1st Mar 2023 7:00 am RNS Incorporation of Inaphaea BioLabs Limited
24th Feb 2023 4:40 pm RNS Second Price Monitoring Extn
FTSE 100 Latest
Value8,809.74
Change53.53